Pediatric Asthma Treatment Market

Pediatric Asthma Treatment Market (Drug Type: Long-term Control Medications and Quick-relief Medications; and Form: Inhalation/Inhalers, Solutions, Pills, and Injections) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Pediatric Asthma Treatment Market Outlook 2031

  • The industry was valued at US$ 11.2 Bn in 2022
  • It is projected to grow at a CAGR of 2.9% from 2023 to 2031 and reach more than US$ 14.4 Bn by the end of 2031

Analysts’ Viewpoint

Rise in environmental irritants and increase in awareness about the severe effects of pediatric asthma are contributing to the global pediatric asthma treatment market growth. Various companies are obtaining FDA approvals for drugs used in the treatment of pediatric asthma.

Leading companies are arranging educative programs for children as well as healthcare professionals regarding the correct usage of inhalers through digital platforms. Rise in participation of several large organizations in spreading knowledge about disease control measures and available treatments for asthma is augmenting market statistics.

Pediatric Asthma Treatment Market

Pediatric Asthma Treatment Market Overview

Pediatric asthma treatment is a medical approach for managing asthma symptoms in children. It typically includes a combination of medications, lifestyle changes, and regular medical check-ups to control airway inflammation, prevent symptoms, and manage sudden attacks. The treatment aims to improve the child's quality of life and prevent complications associated with uncontrolled asthma.

Medications such as bronchodilators and corticosteroids are used to manage acute symptoms and prevent long-term lung damage. Inhaled corticosteroid is the preferred medication for controlling inflammation, as it has fewer side effects than oral steroids.

Lifestyle changes, such as avoiding triggers, improving air quality, and promoting physical activity, are also important components of asthma management. Development of new, targeted therapies and better adherence programs is an area of ongoing research and development in the field of asthma treatment in children.

Increase in Prevalence of Pediatric Asthma

The prevalence of pediatric asthma has increased globally over the past few decades, making it a significant public health concern. Early diagnosis along with proper treatment for asthma is essential to prevent long-term complications in children.

According to the Australian Institute for Health and Welfare, around 10.0% of children between the age of 0 and 14 years suffered from asthma in the country during 2017 to 2018. As per the World Health Organization (WHO), asthma affected around 262 million people globally and led to 4,55,000 deaths in 2019. Thus, increase in prevalence of pediatric asthma across the globe is anticipated to boost pediatric asthma treatment demand in the near future.

CDC’s National Asthma Control Program and asthma camps conducted by the Asthma Society of India offer quality of life for asthma patients through effective disease management techniques.

Rise in Environmental Irritants to Drive Pediatric Asthma Treatment Market Scope

Environmental irritants such as smoke and air pollution can trigger asthma symptoms in children. Smoke from cigarettes, wood-burning stoves, and fireplaces can contain irritants that can inflame the airways and worsen asthma symptoms.

Similarly, air pollution and industrial emissions can also trigger asthma symptoms in kids. In order to minimize exposure to these triggers, it is recommended to avoid smoking indoors, reduce time spent in areas with high air pollution, and use air purifiers. It is also important to work with pediatricians to develop a comprehensive asthma management plan to minimize the frequency and severity of symptoms.

Growth in Awareness About Benefits of Long-term Control Medications

In terms of drug type, the global pediatric asthma treatment market has been classified into long-term control medications and quick-relief medications. The long-term control medications segment dominated the global market in 2021.

Long-term control medications, such as combination inhalers, are gaining traction due to their various benefits. Combination inhalers contain a corticosteroid and a bronchodilator. They help control asthma symptoms more effectively than using either medication alone.

High Demand for Inhalers Augmenting Market Progress

Based on form, the global pediatric asthma treatment market has been segregated into inhalation/inhalers, solutions, pills, and injections. The inhalation/inhalers segment accounted for major share of the global market in 2021.

Inhalers can be a highly effective way to manage asthma symptoms. However, it is important to use them correctly. Inhalers can deliver the medication quickly and effectively. They are also compact and convenient to carry. This is estimated to bolster segment growth.

Rise in Preference for Retail Pharmacies to Purchase Pediatric Asthma Medications

In terms of distribution channel, the market segmentation entails hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is likely to lead the industry in the near future. People prefer retail pharmacies, as they are convenient to purchase pediatric asthma medications.

Regional Analysis of Global Pediatric Asthma Treatment Business

North America is expected to dominate the global landscape during the forecast period. The market in North America is likely to expand at a high CAGR during the forecast period, owing to the high rate of incidence of pediatric asthma in the region.

According to the Center for Disease Control & Prevention (CDC), around 6 million children in the U.S. between the age of 0 and 17 are suffering from asthma. Various companies are carrying out innovations in treatment procedures, considering the high prevalence rate of pediatric asthma in the region. This is contributing to pediatric asthma treatment market growth in North America.

The pediatric asthma treatment market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. According to a study published in the Lung India journal, with an estimated 1.5 crore to 2 crore asthma patients, at least 1 in every 10 asthma patients globally is from India. Furthermore, up to 40.0% of children have a wheeze, which is termed asthma, at some point. Increase in focus on respiratory disease management and rise in awareness about managing pediatric asthma are fueling market expansion in the region.

Analysis of Key Players

The global pediatric asthma treatment market is fragmented, with the presence of large number of local as well as international players. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the leading companies.

Key players of the pediatric asthma treatment industry are ECU Health, AstraZeneca PLC, GlaxoSmithKline, CHIESI Farmaceutici S.p.A., Pfizer Inc., Sanofi, Novartis AG, OPKO Health, Inc., Boehringer Ingelheim International GmbH, and Teva Pharmaceutical Industries Ltd.

Key Developments in Global Pediatric Asthma Treatment Industry

  • In 2022, Sanofi’s Dupixent was approved by the European Medicines Agency as an add-on maintenance therapy for children (6 to 11 years old) with severe asthma with type 2 inflammation.
  • In September 2019, GSK announced the FDA approval for Nucala (mepolizumab), a monoclonal antibody that targets interleukin (IL)-5, for the treatment of severe eosinophilic asthma in children six years and older.

Each of these players has been profiled in the pediatric asthma treatment market report based on parameters such as financial overview, business segments, company overview, recent developments, product portfolio, and business strategies.

Global Pediatric Asthma Treatment Market Snapshot

Attribute

Detail

Market Size Value in 2022

US$ 11.2 Bn

Market Forecast Value in 2031

US$ 14.4 Bn

Growth Rate

(CAGR)

2.9%

Forecast Period

2023–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Drug Type
    • Long-term Control Medications
      • Corticosteroids
      • Leukotriene Modifiers
      • Combination Inhalers
      • Theophylline
      • Others
    • Quick-relief Medications
      • Short-acting Beta Agonists
      • Others
  • Form
    • Inhalation/Inhalers
      • Metered-dose Inhalers
      • Dry Powder Inhalers
    • Solutions
    • Pills
    • Injections
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • CHIESI Farmaceutici S.p.A.
  • ECU Health
  • GlaxoSmithKline
  • Novartis AG
  • OPKO Health, Inc.
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global pediatric asthma treatment market in 2022?

It was valued at US$ 11.2 Bn in 2022

How big will it be in 2031?

It is projected to reach more than US$ 14.4 Bn by 2031

What will be the CAGR during the forecast period (2023–2031)?

The CAGR is anticipated to be 2.9% from 2023 to 2031

What are the prominent trends that affect industry growth?

Rise in incidence of asthma in children and increase in environmental irritants

Which region is likely to account for major share during the forecast period?

North America is expected to account for the largest share during the forecast period

Who are the prominent players in the business?

ECU Health, AstraZeneca PLC, GlaxoSmithKline, CHIESI Farmaceutici S.p.A., Pfizer Inc., Sanofi, Novartis AG, OPKO Health, Inc., Boehringer Ingelheim International GmbH, and Teva Pharmaceutical Industries Ltd.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Pediatric Asthma Treatment Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Pediatric Asthma Treatment Market Analysis and Forecast, 2017- 2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Disease Prevalence & Incidence Rate globally with key countries

        5.3. Key product/brand Analysis

        5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

    6. Global Pediatric Asthma Treatment Market Analysis and Forecast, By Drug Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast By Drug Type, 2017- 2031

            6.3.1. Long-term Control Medications

                6.3.1.1. Corticosteroids

                6.3.1.2. Leukotriene Modifiers

                6.3.1.3. Combination Inhalers

                6.3.1.4. Theophylline

                6.3.1.5. Others

            6.3.2. Quick-relief Medications

                6.3.2.1. Short-acting Beta Agonists

                6.3.2.2. Others

        6.4. Market Attractiveness By Drug Type

    7. Global Pediatric Asthma Treatment Market Analysis and Forecast, By Form

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast By Form, 2017- 2031

            7.3.1. Inhalation/Inhalers

                7.3.1.1. Metered-dose Inhalers

                7.3.1.2. Dry Powder Inhalers

            7.3.2. Solutions (Liquids that can be used in nebulizers)

            7.3.3. Pills

            7.3.4. Injections

        7.4. Market Attractiveness By Form

    8. Global Pediatric Asthma Treatment Market Analysis and Forecast, By Distribution Channel

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast By Distribution Channel, 2017- 2031

            8.3.1. Hospital Pharmacies

            8.3.2. Retail Pharmacies

            8.3.3. Online Pharmacies

        8.4. Market Attractiveness By Distribution Channel

    9. Global Pediatric Asthma Treatment Market Analysis and Forecast, By Region

        9.1. Key Findings

        9.2. Market Value Forecast By Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness By Country/Region

    10. North America Pediatric Asthma Treatment Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast By Drug Type, 2017- 2031

            10.2.1. Long-term Control Medications

                10.2.1.1. Corticosteroids

                10.2.1.2. Leukotriene Modifiers

                10.2.1.3. Combination Inhalers

                10.2.1.4. Theophylline

                10.2.1.5. Others

            10.2.2. Quick-relief Medications

                10.2.2.1. Short-acting Beta Agonists

                10.2.2.2. Others

        10.3. Market Value Forecast By Form, 2017- 2031

            10.3.1. Inhalation/Inhalers

                10.3.1.1. Metered-dose Inhalers

                10.3.1.2. Dry Powder Inhalers

            10.3.2. Solutions (Liquids that can be used in nebulizers)

            10.3.3. Pills

            10.3.4. Injections

        10.4. Market Value Forecast By Distribution Channel, 2017- 2031

            10.4.1. Hospital Pharmacies

            10.4.2. Retail Pharmacies

            10.4.3. Online Pharmacies

        10.5. Market Value Forecast By Country, 2017- 2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Drug Type

            10.6.2. By Form

            10.6.3. By Distribution Channel

            10.6.4. By Country

    11. Europe Pediatric Asthma Treatment Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast By Drug Type, 2017- 2031

            11.2.1. Long-term Control Medications

                11.2.1.1. Corticosteroids

                11.2.1.2. Leukotriene Modifiers

                11.2.1.3. Combination Inhalers

                11.2.1.4. Theophylline

                11.2.1.5. Others

            11.2.2. Quick-relief Medications

                11.2.2.1. Short-acting Beta Agonists

                11.2.2.2. Others

        11.3. Market Value  Forecast By Form, 2017- 2031

            11.3.1. Inhalation/Inhalers

                11.3.1.1. Metered-dose Inhalers

                11.3.1.2. Dry Powder Inhalers

            11.3.2. Solutions (Liquids that can be used in nebulizers)

            11.3.3. Pills

            11.3.4. Injections

        11.4. Market Value Forecast By Distribution Channel, 2017- 2031

            11.4.1. Hospital Pharmacies

            11.4.2. Retail Pharmacies

            11.4.3. Online Pharmacies

        11.5. Market Value Forecast By Country/Sub-region, 2017- 2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Drug Type

            11.6.2. By Form

            11.6.3. By Distribution Channel

            11.6.4. By Country/Sub-region

    12. Asia Pacific Pediatric Asthma Treatment Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast By Drug Type, 2017- 2031

            12.2.1. Long-term Control Medications

                12.2.1.1. Corticosteroids

                12.2.1.2. Leukotriene Modifiers

                12.2.1.3. Combination Inhalers

                12.2.1.4. Theophylline

                12.2.1.5. Others

            12.2.2. Quick-relief Medications

                12.2.2.1. Short-acting Beta Agonists

                12.2.2.2. Others

        12.3. Market Value Forecast By Form, 2017- 2031

            12.3.1. Inhalation/Inhalers

                12.3.1.1. Metered-dose Inhalers

                12.3.1.2. Dry Powder Inhalers

            12.3.2. Solutions (Liquids that can be used in nebulizers)

            12.3.3. Pills

            12.3.4. Injections

        12.4. Market Value Forecast By Distribution Channel, 2017- 2031

            12.4.1. Hospital Pharmacies

            12.4.2. Retail Pharmacies

            12.4.3. Online Pharmacies

        12.5. Market Value  Forecast By Country/Sub-region, 2017- 2031

            12.5.1. Japan

            12.5.2. China

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Drug Type

            12.6.2. By Form

            12.6.3. By Distribution Channel

            12.6.4. By Country/Sub-region

    13. Latin America Pediatric Asthma Treatment Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast By Drug Type, 2017- 2031

            13.2.1. Long-term Control Medications

                13.2.1.1. Corticosteroids

                13.2.1.2. Leukotriene Modifiers

                13.2.1.3. Combination Inhalers

                13.2.1.4. Theophylline

                13.2.1.5. Others

            13.2.2. Quick-relief Medications

                13.2.2.1. Short-acting Beta Agonists

                13.2.2.2. Others

        13.3. Market Value  Forecast By Form, 2017- 2031

            13.3.1. Inhalation/Inhalers

                13.3.1.1. Metered-dose Inhalers

                13.3.1.2. Dry Powder Inhalers

            13.3.2. Solutions (Liquids that can be used in nebulizers)

            13.3.3. Pills

            13.3.4. Injections

        13.4. Market Value Forecast By Distribution Channel, 2017- 2031

            13.4.1. Hospital Pharmacies

            13.4.2. Retail Pharmacies

            13.4.3. Online Pharmacies

        13.5. Market Value Forecast By Country/Sub-region, 2017- 2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Drug Type

            13.6.2. By Form

            13.6.3. By Distribution Channel

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Pediatric Asthma Treatment Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast By Drug Type, 2017- 2031

            14.2.1. Long-term Control Medications

                14.2.1.1. Corticosteroids

                14.2.1.2. Leukotriene Modifiers

                14.2.1.3. Combination Inhalers

                14.2.1.4. Theophylline

                14.2.1.5. Others

            14.2.2. Quick-relief Medications

                14.2.2.1. Short-acting Beta Agonists

                14.2.2.2. Others

        14.3. Market Value  Forecast By Form, 2017- 2031

            14.3.1. Inhalation/Inhalers

                14.3.1.1. Metered-dose Inhalers

                14.3.1.2. Dry Powder Inhalers

            14.3.2. Solutions (Liquids that can be used in nebulizers)

            14.3.3. Pills

            14.3.4. Injections

        14.4. Market Value Forecast By Distribution Channel, 2017- 2031

            14.4.1. Hospital Pharmacies

            14.4.2. Retail Pharmacies

            14.4.3. Online Pharmacies

        14.5. Market Value Forecast By Country/Sub-region, 2017- 2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Drug Type

            14.6.2. By Form

            14.6.3. By Distribution Channel

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player – Competition Matrix (By Tier and Size of companies)

        15.2. Market Share Analysis By Company (2022)

        15.3. Company Profiles

            15.3.1. AstraZeneca PLC

                15.3.1.1. Company Overview

                15.3.1.2. Drug Type Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Strategic Overview

            15.3.2. Boehringer Ingelheim International GmbH

                15.3.2.1. Company Overview

                15.3.2.2. Drug Type Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Strategic Overview

            15.3.3. CHIESI Farmaceutici S.p.A.

                15.3.3.1. Company Overview

                15.3.3.2. Drug Type Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Strategic Overview

            15.3.4. ECU Health

                15.3.4.1. Company Overview

                15.3.4.2. Drug Type Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Strategic Overview

            15.3.5. GlaxoSmithKline

                15.3.5.1. Company Overview

                15.3.5.2. Drug Type Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Strategic Overview

            15.3.6. Novartis AG

                15.3.6.1. Company Overview

                15.3.6.2. Drug Type Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Strategic Overview

            15.3.7. OPKO Health, Inc.

                15.3.7.1. Company Overview

                15.3.7.2. Drug Type Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Strategic Overview

            15.3.8. Pfizer Inc.

                15.3.8.1. Company Overview

                15.3.8.2. Drug Type Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Strategic Overview

            15.3.9. Sanofi

                15.3.9.1. Company Overview

                15.3.9.2. Drug Type Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Strategic Overview

            15.3.10. Teva Pharmaceutical Industries Ltd.

                15.3.10.1. Company Overview

                15.3.10.2. Drug Type Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Strategic Overview

    List of Tables

    Table 01: Global Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2017‒2031

    Table 02: Global Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Form, 2017‒2031

    Table 03: Global Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel 2017–2031

    Table 04: Global Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2017‒2031

    Table 07: North America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Form, 2017‒2031

    Table 08: North America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel 2017–2031

    Table 09: Europe Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

    Table 10: Europe Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2017‒2031

    Table 11: Europe Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Form, 2017‒2031

    Table 12: Europe Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel 2017–2031

    Table 13: Asia Pacific Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2017‒2031

    Table 15: Asia Pacific Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Form, 2017‒2031

    Table 16: Asia Pacific Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel 2017–2031

    Table 17: Latin America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2017‒2031

    Table 19: Latin America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Form, 2017‒2031

    Table 20: Latin America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

    Table 21: Middle East & Africa Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2017‒2031

    Table 23: Middle East & Africa Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Form, 2017‒2031

    Table 24: Middle East & Africa Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel 2017–2031

    List of Figures

    Figure 01: Global Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Pediatric Asthma Treatment Market Value Share, by Drug Type, 2021

    Figure 03: Pediatric Asthma Treatment Market Value Share, by Form, 2021

    Figure 04: Pediatric Asthma Treatment Market Value Share, by Distribution Channel, 2021

    Figure 05: Pediatric Asthma Treatment Market Value Share, by Region, 2021

    Figure 06: Global Pediatric Asthma Treatment Market Value Share Analysis, by Drug Type, 2021 and 2031

    Figure 07: Global Pediatric Asthma Treatment Market Attractiveness Analysis, by Drug Type, 2022–2031

    Figure 08: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Long-term Control Medications, 2017‒2031

    Figure 09: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Corticosteroids, 2017‒2031

    Figure 10: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Leukotriene Modifiers, 2017‒2031

    Figure 11: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Combination Inhalers, 2017‒2031

    Figure 12: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Theophylline, 2017‒2031

    Figure 13: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Others 2017‒2031

    Figure 14: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Quick-relief Medications 2017‒2031

    Figure 15: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Short-acting Beta Agonists 2017‒2031

    Figure 16: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Others 2017‒2031

    Figure 17: Global Pediatric Asthma Treatment Market Value Share Analysis, by Form, 2021 and 2031

    Figure 18: Global Pediatric Asthma Treatment Market Attractiveness Analysis, by Form, 2022–2031

    Figure 19: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Inhalation/Inhalers, 2017‒2031

    Figure 20: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Solution, 2017‒2031

    Figure 21: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Pills, 2017‒2031

    Figure 22: Global Pediatric Asthma Treatment Market Value (US$ Mn), by Injections, 2017‒2031

    Figure 23: Global Pediatric Asthma Treatment Market Value Share Analysis, by Distribution Channel 2021 and 2031

    Figure 24: Global Pediatric Asthma Treatment Market Attractiveness Analysis, by Distribution Channel 2022–2031

    Figure 25: Global Pediatric Asthma Treatment Market Revenue (US$ Mn), by Hospital Pharmacies, 2017–2031

    Figure 26: Global Pediatric Asthma Treatment Market Revenue (US$ Mn), by Retail Pharmacies, 2017–2031

    Figure 27: Global Pediatric Asthma Treatment Market Revenue (US$ Mn), by Online Pharmacies, 2017–2031

    Figure 28: Global Pediatric Asthma Treatment Market Value Share Analysis, by Region, 2021 and 2031

    Figure 29: Global Pediatric Asthma Treatment Market Attractiveness Analysis, by Region, 2022–2031

    Figure 30: North America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 31: North America Pediatric Asthma Treatment Market Value Share Analysis, by Country, 2021 and 2031

    Figure 32: North America Pediatric Asthma Treatment Market Attractiveness Analysis, by Country, 2022–2031

    Figure 33: North America Pediatric Asthma Treatment Market Value Share Analysis, by Drug Type, 2021 and 2031

    Figure 34: North America Pediatric Asthma Treatment Market Attractiveness Analysis, by Drug Type 2022–2031

    Figure 35: North America Pediatric Asthma Treatment Market Value Share Analysis, by Form, 2021 and 2031

    Figure 36: North America Pediatric Asthma Treatment Market Attractiveness Analysis, by Form 2022–2031

    Figure 37: North America Pediatric Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 38: North America Pediatric Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 39: Europe Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 40: Europe Pediatric Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 41: Europe Pediatric Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 42: Europe Pediatric Asthma Treatment Market Value Share Analysis, by Drug Type, 2021 and 2031

    Figure 43: Europe Pediatric Asthma Treatment Market Attractiveness Analysis, by Drug Type, 2022–2031

    Figure 44: Europe Pediatric Asthma Treatment Market Value Share Analysis, by Form, 2021 and 2031

    Figure 45: Europe Pediatric Asthma Treatment Market Attractiveness Analysis, by Form, 2022–2031

    Figure 46: Europe Pediatric Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 47: Europe Pediatric Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 48: Asia Pacific Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 49: Asia Pacific Pediatric Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 50: Asia Pacific Pediatric Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 51: Asia Pacific Pediatric Asthma Treatment Market Value Share Analysis, by Drug Type, 2021 and 2031

    Figure 52: Asia Pacific Pediatric Asthma Treatment Market Attractiveness Analysis, by Drug Type, 2022–2031

    Figure 53: Asia Pacific Pediatric Asthma Treatment Market Value Share Analysis, by Form, 2021 and 2031

    Figure 54: Asia Pacific Pediatric Asthma Treatment Market Attractiveness Analysis, by Form, 2022–2031

    Figure 55: Asia Pacific Pediatric Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 56: Asia Pacific Pediatric Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 57: Latin America Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 58: Latin America Pediatric Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 59: Latin America Pediatric Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 60: Latin America Pediatric Asthma Treatment Market Value Share Analysis, by Drug Type, 2021 and 2031

    Figure 61: Latin America Pediatric Asthma Treatment Market Attractiveness Analysis, by Drug Type, 2022–2031

    Figure 62: Latin America Pediatric Asthma Treatment Market Value Share Analysis, by Form, 2021 and 2031

    Figure 63: Latin America Pediatric Asthma Treatment Market Attractiveness Analysis, by Form, 2022–2031

    Figure 64: Latin America Pediatric Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 65: Latin America Pediatric Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 66: Middle East & Africa Pediatric Asthma Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 67: Middle East & Africa Pediatric Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 68: Middle East & Africa Pediatric Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 69: Middle East & Africa Pediatric Asthma Treatment Market Value Share Analysis, by Drug Type, 2021 and 2031

    Figure 70: Middle East & Africa Pediatric Asthma Treatment Market Attractiveness Analysis, by Drug Type, 2022–2031

    Figure 71: Middle East & Africa Pediatric Asthma Treatment Market Value Share Analysis, by Form, 2021 and 2031

    Figure 72: Middle East & Africa Pediatric Asthma Treatment Market Attractiveness Analysis, by Form, 2022–2031

    Figure 73: Middle East & Africa Pediatric Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2021 and 2031

    Figure 74: Middle East & Africa Pediatric Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2022–2031

    Figure 75: Company Share Analysis

Copyright © Transparency Market Research, Inc. All Rights reserved